Search Results

You are looking at 1 - 7 of 7 items for :

  • nuclear program x
  • Endocrinology, Diabetology x
Clear All
Open access

Carmen Bogeanu, Cristiana David, Ileana Peride, Ionel Alexandru Checheriţă and Alexandru Ciocâlteu

Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50: e159-e241, 2007. 9. Chamberlain D. Preoperative risk evaluation: an old school approach with a few new tools. Accessed on 5 October 2013 at: 10. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting

Open access

Chuan Li, Lili Qu, Cullen Farragher, Anthony Vella and Beiyan Zhou

facilitate the induction of genes under the regulation of PPARγ.[ 57 ] Similarly, liver X receptors (LXRs; nuclear transcription factors that heterodimerize with the retinoid X receptor RXRα) contribute to reduced pro-inflammatory signaling.[ 58 , 59 , 60 ] Indeed, LXRs have long been recognized for their role in the amelioration of autoimmune diseases and regression of atherosclerotic plaques, which are extensively orchestrated by M2 macrophages.[ 61 , 62 ] In recent years, increasing evidence supports the critical roles of miRNAs in regulating macrophage activation

Open access

Justin S. Michael, Bong-Seop Lee, Miqin Zhang and John S. Yu

blood vessels of human glioblastoma multiforme. Acta Neuropathol 2000;100:323-31. 10.1007/s004010000180 Liebner S Fischmann A Rascher G Duffner F Grote EH Kalbacher H et al Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme Acta Neuropathol 2000 100 323 – 31 8 Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al . IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006;177:5574-84. 10.4049/jimmunol

Open access

Ling Wang and Chandra Mohan

-aminohippurate (PAH) or a radioisotope tracer. Although PAH still remains a gold standard, the technical difficulties associated with its use have limited its routine application in the clinic, although it is commonly used for research. Nuclear medicine based techniques also pose problems such as requiring time for excretion of the injected radioisotopes out of the body, and concerns regarding radioisotope exposure. Against this backdrop, CEUS offers a novel approach for RBF evaluation, without the above-mentioned concerns, as it appears to be fast, noninvasive, and safe

Open access

Dibyendu Dutta, In Park, Hiwot Guililat, Samuel Sang, Arpita Talapatra, Barkha Singhal and Nathaniel C. Mills

substrate specifi city that only partially overlaps with granzyme A. J Biol Chem 284, 3504-3512, 2009. Buzza MS, Bird PI. Extracellular granzymes: current perspectives. Biol Chem 387, 827-837, 2006. Chavez-Galan L, Arenas-Del Angel, MC, Zenteno E, Chavez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 6), 15-25, 2009. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 26, 389-420, 2008. Dutta D, Guililat H

Open access

Frederick-Anthony Farrugia, Nicolaos Zavras, Georgios Martikos, Panagiotis Tzanetis, Anestis Charalampopoulos, Evangelos P. Misiakos, Dimitrios Sotiropoulos and Nikolaos Koliakos

, Khuri S, Hanks JB, Inabnet WB 3rd. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg 206, 953-961, 2008. Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 26, 1816-1823, 2008. Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism

Open access

FA Farrugia, G Martikos, P Tzanetis, A Charalampopoulos, E Misiakos, N Zavras and D Sotiropoulos

–311, 2010. Mittendorf EA, Evans DB, Lee JE, Perrier ND. Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. Hematol Oncol Clin North Am 21, 509–525, 2007. Miyake H, Maeda H, Tashiro M, Suzuki K, Nagatomo H, Aikawa H, Ashizawa A, Iechika S, Moriuchi A. CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 152, 1005–1007, 1989. Moon KL Jr, Hricak H, Crooks LE, Gooding CA, Moss AA, Engelstad BL, Kaufman L. Nuclear magnetic resonance imaging of the adrenal gland: a preliminary